Aneesh B. Singhal, MD, FAHA, FAAN, FANA

Dr. Aneesh B. Singhal is vice-chair of Neurology Quality & Safety, director of the Advanced Comprehensive Stroke Center director, and the Lee H. Schwamm, MD, is a Board-Designated endowed chair in Innovation, Technology, and Stroke Research at Massachusetts General Hospital (MGH). He is the principal investigator of the New England Regional Coordinating Center (NERCC) for the NIH-funded stroke clinical trials network StrokeNet. He is a board-certified neurologist, vascular neurologist, neurosonologist, and associate professor of Neurology at Harvard Medical School. He is an elected fellow of the American Neurological Association, the American Academy of Neurology, and the American Heart Association. He is the past president of the Association of Indian Neurologists in the USA. He has served on the Board of Trustees of the Mass General Brigham Continuing Care and Spaulding Rehabilitation Network and the Neurology Foundation India. Dr. Singhal co-directs the Clinical Trials module of the Harvard Medical School Master of Medical Sciences in Clinical Investigation (MMSCI) program and teaches in several other HMS courses.

Dr. Singhal’s areas of research include stroke clinical trials, stroke in young adults, cerebral arteriopathies, advanced brain imaging for acute ischemic stroke, and stroke neuroprotection. He is internationally recognized for his work on the role of normobaric oxygen therapy in acute stroke and for characterizing stroke syndromes such as the reversible cerebral vasoconstriction syndrome (RCVS), primary angiitis of the central nervous system (PACNS), and post-stroke recrudescence (PSR). He has developed numerous innovative clinical care pathways and guidelines, most notably the “TIA/Minor Stroke” pathway, for which he received the Nathanial Bowditch Award from the MGH Center for Quality and Safety and the 2023 quality innovation award from the American Academy of Neurology. Dr. Singhal has hosted observers from 38 countries, many of whom are now stroke leaders in their home countries. He has served as the Principal Investigator of several NIH and industry-funded stroke clinical trials. Dr. Singhal has authored or co-authored over 250 articles and book chapters.